圣达生物：8000万元闲置募资现金管理产品到期赎回

Core Viewpoint - The company has approved the use of up to 230 million yuan of idle raised funds for cash management, indicating a strategic approach to optimize financial resources [1] Group 1: Fund Management - On October 14, the company utilized 80 million yuan of idle raised funds to purchase a customized structured deposit product from China Construction Bank's Zhejiang branch [1] - The structured deposit product matured on December 22, with the company recovering the principal of 80 million yuan along with an interest income of 286,200 yuan, which was returned to the raised funds account [1] - The returns from the investment were in line with expectations, showing no significant discrepancies [1]